Submitted abstractsAdvanced NSCLC113O - Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001
Advanced NSCLC
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2019 THE AUTHORS. Published by Elsevier Ltd. All rights reserved.